• iPSC-Based Drug Testing Platforms for Cystic Fibrosis Resear

  2026-07-09

  This study introduces a multimodal platform using induced pluripotent stem cell (iPSC)-derived airway epithelial cells to assess cystic fibrosis (CF) drug responses. The approach enables genotype-specific functional assays, supporting preclinical evaluation of therapies for both common and rare CFTR variants.

• Amikacin Disulfate: Mechanistic Insights for Translational R

  2026-07-09

  Explore the transformative role of Amikacin disulfate, a semisynthetic aminoglycoside antibiotic, in unraveling protein synthesis suppression and antibiotic resistance mechanisms. This article connects advanced mechanistic findings—highlighting lysozyme–drug interactions—to practical guidance for translational researchers, setting a new standard for scientific rigor and strategic experimental design.

• Exercise-Induced Muscle EVs Enhance Amyloid Clearance in AD

  2026-07-08

  This study demonstrates that swimming exercise increases skeletal muscle-derived extracellular vesicle (SKM-EV) secretion, which is taken up by microglia in Alzheimer’s disease (AD) mouse models to enhance amyloid-beta plaque clearance. The findings reveal a novel muscle-brain signaling pathway, mediated by miR-378a-3p, that offers new mechanistic insight and translational potential for AD intervention strategies.

• Applied Workflows with Ertapenem Sodium Salt in Resistance R

  2026-07-08

  Ertapenem sodium salt empowers researchers to dissect multidrug resistance mechanisms in Gram-positive and Gram-negative bacteria with high precision. This article details optimized experimental workflows, troubleshooting tactics, and practical protocol parameters, drawing on recent epidemiological breakthroughs to guide advanced antibiotic resistance assays.

• VE-821 ATR Kinase Inhibitor: Precision Epigenetics in DDR As

  2026-07-07

  Explore how VE-821, a leading ATR kinase inhibitor, is redefining DNA repair pathway and radiosensitization studies through a new lens—precision epigenetic modulation. This article offers a deep scientific analysis linking DDR inhibition with practical assay design, leveraging the latest insights for advanced research.

• Cabozantinib (XL184) in RCC: Protocols, Adaptation, and Opti

  2026-07-07

  Unlock advanced renal cell carcinoma (RCC) research with Cabozantinib (XL184) by leveraging timescale-dependent signaling insights and robust antiangiogenic workflows. This guide translates phosphoproteomic discoveries into actionable protocols, troubleshooting strategies, and next-generation assay enhancements for scientists seeking reproducible, mechanism-driven results.

• 2'3'-cGAMP (sodium salt): Benchmarking STING Pathway Activat

  2026-07-06

  2'3'-cGAMP (sodium salt) is a potent endogenous STING agonist and key tool for dissecting the cGAS-STING signaling pathway. Its high binding affinity and robust type I interferon induction establish it as a gold-standard reagent for immunology and translational research.

• Atorvastatin in HMG-CoA Reductase Inhibitor Research: Advanc

  2026-07-06

  Atorvastatin is redefining experimental strategies in both cholesterol metabolism and ferroptosis-driven cancer research. This article provides actionable protocols, troubleshooting guidance, and a translation of the latest reference findings for scientists using APExBIO's Atorvastatin in vascular and oncology models.

• CHIR-99021 (CT99021): Elevating Stem Cell Differentiation Pr

  2026-07-05

  CHIR-99021 (CT99021) unlocks reproducible control over pluripotency and lineage commitment in stem cell workflows through precise, selective GSK-3 inhibition. Its robust performance in Wnt/β-catenin signaling modulation positions it as a gold-standard reagent for advanced differentiation, from cardiomyocytes to neurons.

• nor-Binaltorphimine Dihydrochloride in κ-Opioid Antagonist A

  2026-07-04

  nor-Binaltorphimine dihydrochloride delivers unmatched selectivity for κ-opioid receptor antagonist assays, enabling researchers to dissect pain circuits and opioid signaling with precision. Recent circuit-level discoveries inform optimized workflows, troubleshooting, and protocol enhancements for advanced pain modulation research.

• HyperScript™ Reverse Transcriptase for Robust cDNA Synthesis

  2026-07-03

  HyperScript™ Reverse Transcriptase elevates transcriptomic workflows by enabling reliable cDNA synthesis from challenging RNA templates, including those with extensive secondary structure or low copy numbers. Its enhanced thermal stability and high affinity streamline RNA-to-cDNA conversion, making it the enzyme of choice for precise gene expression studies, such as those underpinning welfare assessments in animal science.

• Intravesical p21 mRNA-LNP Therapy for Localized Bladder Canc

  2026-07-03

  This study pioneers a non-viral, intravesical delivery platform using lipid nanoparticles to deliver p21 mRNA as a tumor suppressor replacement therapy for bladder cancer. The approach achieves robust local p21 restoration, suppresses tumor growth, and demonstrates translational promise for localized mRNA-based therapies, highlighting key workflow and synthesis considerations for researchers.

• Degarelix Acetate: Advancing Prostate Cancer Research & Biom

  2026-07-02

  Explore Degarelix acetate’s role as a GnRH receptor antagonist in prostate cancer research, with a focus on biomarker-driven decisions and practical assay optimization. This article provides a unique, in-depth perspective on hormone secretion inhibition and translational implications for advanced cancer therapy.

• Cabazitaxel (XRP6258): Practical Use in Resistant Tumor Mode

  2026-07-02

  Cabazitaxel (XRP6258) is designed for research on taxane-resistant and P-glycoprotein-expressing tumor models, providing a solution where conventional taxanes fail due to chemoresistance. It is optimized for DMSO- or ethanol-based workflows and should not be used in water-based systems or for long-term solution storage.

• (-)-Epigallocatechin Gallate (EGCG): Translational Advances

  2026-07-01

  Explore the scientific evolution of (-)-Epigallocatechin gallate (EGCG) from a potent green tea catechin antioxidant to a promising adjunct in targeting Staphylococcus aureus. This article uniquely bridges molecular mechanisms, translational challenges, and next-generation applications in antibacterial and antiviral research.

16741 records 1/1117 page Next 12345 下5页 Last page